Author

B. Lal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Anbarasu· 1 shared A. Naha· 1 shared A. Quinones-Hinojosa· 1 shared A. X. Mekile· 1 shared B. A. Shankar· 1 shared B. Veeraraghavan· 1 shared D. K. Rathore· 1 shared G. Joshi· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Anbarasu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo

K. Jakhar, S. Sonar, G. Singh, T. R. Asuru, G. Joshi, N. Beniwal, T. Sarkar, M. Tiwari, J. Kaur, D. K. Rathore, B. Lal, S. Kumar, P. Srivastav, S. Kumar, V. Phagna, , S. Mani

The paper shows that SARS-CoV-2 spike antibodies can enhance DENV2 infection in vitro and in vivo, suggesting potential for increased dengue severity in COVID-19 survivors.

bioRxiv · Oct 9, 2023Immunology

The Endosomal pH Regulator NHE9 is a Driver of Stemness in Glioblastoma

M. Ko, M. R. Makena, P. V. Schiapparelli, P. Suarez Meade, A. X. Mekile, B. Lal, H. Lopez-Bertoni, J. Laterra, A. Quinones-Hinojosa, R. Rao

This paper identifies NHE9 as a driver of stemness in glioblastoma by showing it increases receptor tyrosine kinase stability and activates JAK2-STAT3 to induce pluripotency genes.

bioRxiv · Oct 7, 2021Cancer Biology

Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of Sulbactam-Durlobactam holds promise for therapeutic intervention

A. Naha, S. Vijayakumar, B. Lal, B. A. Shankar, S. Chandran, S. Ramaiah, B. Veeraraghavan, A. Anbarasu

This study characterizes drug resistance in XDR Acinetobacter baumannii isolates and evaluates the efficacy of the novel Sulbactam-Durlobactam combination against carbapenemases.

bioRxiv · Aug 22, 2021Microbiology